共 50 条
- [1] Exemestane as primary treatment of oestrogen receptor-positive breast cancer in postmenopausal women: a phase II trial[J]. British Journal of Cancer, 2009, 100 : 442 - 449A Barnadas论文数: 0 引用数: 0 h-index: 0机构: Hospital Universitari Germans Trias i Pujol,Medical Oncology DepartmentM Gil论文数: 0 引用数: 0 h-index: 0机构: Hospital Universitari Germans Trias i Pujol,Medical Oncology DepartmentS González论文数: 0 引用数: 0 h-index: 0机构: Hospital Universitari Germans Trias i Pujol,Medical Oncology DepartmentI Tusquets论文数: 0 引用数: 0 h-index: 0机构: Hospital Universitari Germans Trias i Pujol,Medical Oncology DepartmentM Muñoz论文数: 0 引用数: 0 h-index: 0机构: Hospital Universitari Germans Trias i Pujol,Medical Oncology DepartmentA Arcusa论文数: 0 引用数: 0 h-index: 0机构: Hospital Universitari Germans Trias i Pujol,Medical Oncology DepartmentL Prieto论文数: 0 引用数: 0 h-index: 0机构: Hospital Universitari Germans Trias i Pujol,Medical Oncology DepartmentM Margelí-Vila论文数: 0 引用数: 0 h-index: 0机构: Hospital Universitari Germans Trias i Pujol,Medical Oncology DepartmentA Moreno论文数: 0 引用数: 0 h-index: 0机构: Hospital Universitari Germans Trias i Pujol,Medical Oncology Department
- [2] Phase I trial of exemestane in combination with metformin and rosiglitazone in nondiabetic obese postmenopausal women with hormone receptor-positive metastatic breast cancer[J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (01) : 63 - 72Esteva, Francisco J.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Unit 1354, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Unit 1354, Houston, TX 77030 USAMoulder, Stacy L.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Unit 1354, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Unit 1354, Houston, TX 77030 USAGonzalez-Angulo, Ana M.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Unit 1354, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Unit 1354, Houston, TX 77030 USAEnsor, Joe论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Unit 1354, Houston, TX 77030 USAMurray, James L.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Unit 1354, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Unit 1354, Houston, TX 77030 USAGreen, Marjorie C.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Unit 1354, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Unit 1354, Houston, TX 77030 USAKoenig, Kimberly B.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Unit 1354, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Unit 1354, Houston, TX 77030 USALee, Mong-Hong论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Unit 1354, Houston, TX 77030 USAHortobagyi, Gabriel N.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Unit 1354, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Unit 1354, Houston, TX 77030 USAYeung, Sai-Ching论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Emergency Med, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Endocrine Neoplasia & Hormonal Disorders, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Unit 1354, Houston, TX 77030 USA
- [3] Effects of fulvestrant in premenopausal women with oestrogen receptor-positive primary breast cancer[J]. EJC SUPPLEMENTS, 2004, 2 (03): : 73 - 74Robertson, J.论文数: 0 引用数: 0 h-index: 0机构: City Hosp Nottingham, Nottingham, England City Hosp Nottingham, Nottingham, EnglandSemiglazov, V.论文数: 0 引用数: 0 h-index: 0机构: NN Petrov Oncol Res Inst, St Petersburg, Russia City Hosp Nottingham, Nottingham, EnglandGee, J.论文数: 0 引用数: 0 h-index: 0机构: Tenovus Ctr Canc Res, Cardiff, Wales City Hosp Nottingham, Nottingham, EnglandArmstrong, J.论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Macclesfield, Cheshire, England City Hosp Nottingham, Nottingham, England
- [4] Figitumumab Plus Exemestane Versus Exemestane as First-Line Treatment of Postmenopausal Hormone Receptor-Positive Advanced Breast Cancer: A Randomized, Open-Label Phase II Trial[J]. CANCER RESEARCH, 2011, 71Ryan, P. D.论文数: 0 引用数: 0 h-index: 0机构: Fox Chase Canc Ctr, Philadelphia, PA 19111 USA Univ Ziekenhuis Leuven, Leuven, Belgium Duke Univ, Med Ctr, Durham, NC USA Sint Augustinus, Oncol Ctr, Antwerp, Belgium PUCRS Sch Med, Porto Alegre, RS, Brazil McGill Univ, Jewish Gen Hosp, Segal Canc Ctr, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada Ctr Oncol Rosario, Santa Fe, Argentina Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada Pfizer Inc, Groton, CT 06340 USA Univ Minnesota, Minneapolis, MN USA Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA Fox Chase Canc Ctr, Philadelphia, PA 19111 USANeven, P.论文数: 0 引用数: 0 h-index: 0机构: Fox Chase Canc Ctr, Philadelphia, PA 19111 USA Univ Ziekenhuis Leuven, Leuven, Belgium Duke Univ, Med Ctr, Durham, NC USA Sint Augustinus, Oncol Ctr, Antwerp, Belgium PUCRS Sch Med, Porto Alegre, RS, Brazil McGill Univ, Jewish Gen Hosp, Segal Canc Ctr, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada Ctr Oncol Rosario, Santa Fe, Argentina Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada Pfizer Inc, Groton, CT 06340 USA Univ Minnesota, Minneapolis, MN USA Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA Fox Chase Canc Ctr, Philadelphia, PA 19111 USABlackwell, K. L.论文数: 0 引用数: 0 h-index: 0机构: Fox Chase Canc Ctr, Philadelphia, PA 19111 USA Univ Ziekenhuis Leuven, Leuven, Belgium Duke Univ, Med Ctr, Durham, NC USA Sint Augustinus, Oncol Ctr, Antwerp, Belgium PUCRS Sch Med, Porto Alegre, RS, Brazil McGill Univ, Jewish Gen Hosp, Segal Canc Ctr, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada Ctr Oncol Rosario, Santa Fe, Argentina Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada Pfizer Inc, Groton, CT 06340 USA Univ Minnesota, Minneapolis, MN USA Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA Fox Chase Canc Ctr, Philadelphia, PA 19111 USADirix, L. Y.论文数: 0 引用数: 0 h-index: 0机构: Fox Chase Canc Ctr, Philadelphia, PA 19111 USA Univ Ziekenhuis Leuven, Leuven, Belgium Duke Univ, Med Ctr, Durham, NC USA Sint Augustinus, Oncol Ctr, Antwerp, Belgium PUCRS Sch Med, Porto Alegre, RS, Brazil McGill Univ, Jewish Gen Hosp, Segal Canc Ctr, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada Ctr Oncol Rosario, Santa Fe, Argentina Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada Pfizer Inc, Groton, CT 06340 USA Univ Minnesota, Minneapolis, MN USA Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA Fox Chase Canc Ctr, Philadelphia, PA 19111 USABarrios, C. H.论文数: 0 引用数: 0 h-index: 0机构: Fox Chase Canc Ctr, Philadelphia, PA 19111 USA Univ Ziekenhuis Leuven, Leuven, Belgium Duke Univ, Med Ctr, Durham, NC USA Sint Augustinus, Oncol Ctr, Antwerp, Belgium PUCRS Sch Med, Porto Alegre, RS, Brazil McGill Univ, Jewish Gen Hosp, Segal Canc Ctr, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada Ctr Oncol Rosario, Santa Fe, Argentina Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada Pfizer Inc, Groton, CT 06340 USA Univ Minnesota, Minneapolis, MN USA Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA Fox Chase Canc Ctr, Philadelphia, PA 19111 USAMiller, W. H., Jr.论文数: 0 引用数: 0 h-index: 0机构: Fox Chase Canc Ctr, Philadelphia, PA 19111 USA Univ Ziekenhuis Leuven, Leuven, Belgium Duke Univ, Med Ctr, Durham, NC USA Sint Augustinus, Oncol Ctr, Antwerp, Belgium PUCRS Sch Med, Porto Alegre, RS, Brazil McGill Univ, Jewish Gen Hosp, Segal Canc Ctr, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada Ctr Oncol Rosario, Santa Fe, Argentina Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada Pfizer Inc, Groton, CT 06340 USA Univ Minnesota, Minneapolis, MN USA Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA Fox Chase Canc Ctr, Philadelphia, PA 19111 USAFein, L. E.论文数: 0 引用数: 0 h-index: 0机构: Fox Chase Canc Ctr, Philadelphia, PA 19111 USA Univ Ziekenhuis Leuven, Leuven, Belgium Duke Univ, Med Ctr, Durham, NC USA Sint Augustinus, Oncol Ctr, Antwerp, Belgium PUCRS Sch Med, Porto Alegre, RS, Brazil McGill Univ, Jewish Gen Hosp, Segal Canc Ctr, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada Ctr Oncol Rosario, Santa Fe, Argentina Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada Pfizer Inc, Groton, CT 06340 USA Univ Minnesota, Minneapolis, MN USA Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA Fox Chase Canc Ctr, Philadelphia, PA 19111 USAFenton, D.论文数: 0 引用数: 0 h-index: 0机构: Fox Chase Canc Ctr, Philadelphia, PA 19111 USA Univ Ziekenhuis Leuven, Leuven, Belgium Duke Univ, Med Ctr, Durham, NC USA Sint Augustinus, Oncol Ctr, Antwerp, Belgium PUCRS Sch Med, Porto Alegre, RS, Brazil McGill Univ, Jewish Gen Hosp, Segal Canc Ctr, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada Ctr Oncol Rosario, Santa Fe, Argentina Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada Pfizer Inc, Groton, CT 06340 USA Univ Minnesota, Minneapolis, MN USA Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA Fox Chase Canc Ctr, Philadelphia, PA 19111 USABenner, R. J.论文数: 0 引用数: 0 h-index: 0机构: Fox Chase Canc Ctr, Philadelphia, PA 19111 USA Univ Ziekenhuis Leuven, Leuven, Belgium Duke Univ, Med Ctr, Durham, NC USA Sint Augustinus, Oncol Ctr, Antwerp, Belgium PUCRS Sch Med, Porto Alegre, RS, Brazil McGill Univ, Jewish Gen Hosp, Segal Canc Ctr, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada Ctr Oncol Rosario, Santa Fe, Argentina Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada Pfizer Inc, Groton, CT 06340 USA Univ Minnesota, Minneapolis, MN USA Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA Fox Chase Canc Ctr, Philadelphia, PA 19111 USAMeech, S. J.论文数: 0 引用数: 0 h-index: 0机构: Fox Chase Canc Ctr, Philadelphia, PA 19111 USA Univ Ziekenhuis Leuven, Leuven, Belgium Duke Univ, Med Ctr, Durham, NC USA Sint Augustinus, Oncol Ctr, Antwerp, Belgium PUCRS Sch Med, Porto Alegre, RS, Brazil McGill Univ, Jewish Gen Hosp, Segal Canc Ctr, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada Ctr Oncol Rosario, Santa Fe, Argentina Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada Pfizer Inc, Groton, CT 06340 USA Univ Minnesota, Minneapolis, MN USA Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA Fox Chase Canc Ctr, Philadelphia, PA 19111 USAPaccagnella, L.论文数: 0 引用数: 0 h-index: 0机构: Fox Chase Canc Ctr, Philadelphia, PA 19111 USA Univ Ziekenhuis Leuven, Leuven, Belgium Duke Univ, Med Ctr, Durham, NC USA Sint Augustinus, Oncol Ctr, Antwerp, Belgium PUCRS Sch Med, Porto Alegre, RS, Brazil McGill Univ, Jewish Gen Hosp, Segal Canc Ctr, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada Ctr Oncol Rosario, Santa Fe, Argentina Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada Pfizer Inc, Groton, CT 06340 USA Univ Minnesota, Minneapolis, MN USA Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA Fox Chase Canc Ctr, Philadelphia, PA 19111 USASleight, B.论文数: 0 引用数: 0 h-index: 0机构: Fox Chase Canc Ctr, Philadelphia, PA 19111 USA Univ Ziekenhuis Leuven, Leuven, Belgium Duke Univ, Med Ctr, Durham, NC USA Sint Augustinus, Oncol Ctr, Antwerp, Belgium PUCRS Sch Med, Porto Alegre, RS, Brazil McGill Univ, Jewish Gen Hosp, Segal Canc Ctr, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada Ctr Oncol Rosario, Santa Fe, Argentina Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada Pfizer Inc, Groton, CT 06340 USA Univ Minnesota, Minneapolis, MN USA Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA Fox Chase Canc Ctr, Philadelphia, PA 19111 USAYee, D.论文数: 0 引用数: 0 h-index: 0机构: Fox Chase Canc Ctr, Philadelphia, PA 19111 USA Univ Ziekenhuis Leuven, Leuven, Belgium Duke Univ, Med Ctr, Durham, NC USA Sint Augustinus, Oncol Ctr, Antwerp, Belgium PUCRS Sch Med, Porto Alegre, RS, Brazil McGill Univ, Jewish Gen Hosp, Segal Canc Ctr, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada Ctr Oncol Rosario, Santa Fe, Argentina Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada Pfizer Inc, Groton, CT 06340 USA Univ Minnesota, Minneapolis, MN USA Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA Fox Chase Canc Ctr, Philadelphia, PA 19111 USAGoss, P. E.论文数: 0 引用数: 0 h-index: 0机构: Fox Chase Canc Ctr, Philadelphia, PA 19111 USA Univ Ziekenhuis Leuven, Leuven, Belgium Duke Univ, Med Ctr, Durham, NC USA Sint Augustinus, Oncol Ctr, Antwerp, Belgium PUCRS Sch Med, Porto Alegre, RS, Brazil McGill Univ, Jewish Gen Hosp, Segal Canc Ctr, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada Ctr Oncol Rosario, Santa Fe, Argentina Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada Pfizer Inc, Groton, CT 06340 USA Univ Minnesota, Minneapolis, MN USA Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA Fox Chase Canc Ctr, Philadelphia, PA 19111 USA
- [5] Efficacy of Alternative Dose Regimens of Exemestane in Postmenopausal Women With Stage 0 to II Estrogen Receptor-Positive Breast Cancer A Randomized Clinical Trial[J]. JAMA ONCOLOGY, 2023, 9 (05) : 664 - 672论文数: 引用数: h-index:机构:论文数: 引用数: h-index:机构:Thomas, Parjhitham论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX USA IRCCS, European Inst Oncol, Milan, ItalyCrew, Katherine D.论文数: 0 引用数: 0 h-index: 0机构: Columbia Univ, Irving Med Ctr, New York, NY USA IRCCS, European Inst Oncol, Milan, ItalyKumar, Nagi B.论文数: 0 引用数: 0 h-index: 0机构: Univ S Florida, Moffitt Canc Ctr, Tampa, FL USA IRCCS, European Inst Oncol, Milan, ItalyVornik, Lana A.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX USA IRCCS, European Inst Oncol, Milan, ItalyLee, J. Jack论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX USA IRCCS, European Inst Oncol, Milan, ItalyVeronesi, Paolo论文数: 0 引用数: 0 h-index: 0机构: IRCCS, European Inst Oncol, Milan, Italy IRCCS, European Inst Oncol, Milan, ItalyViale, Giuseppe论文数: 0 引用数: 0 h-index: 0机构: IRCCS, European Inst Oncol, Milan, Italy IRCCS, European Inst Oncol, Milan, ItalyGuerrieri-Gonzaga, Aliana论文数: 0 引用数: 0 h-index: 0机构: IRCCS, European Inst Oncol, Milan, Italy IRCCS, European Inst Oncol, Milan, Italy论文数: 引用数: h-index:机构:Johansson, Harriet论文数: 0 引用数: 0 h-index: 0机构: IRCCS, European Inst Oncol, Milan, Italy IRCCS, European Inst Oncol, Milan, ItalyD'Amico, Mauro论文数: 0 引用数: 0 h-index: 0机构: Ospedali Galliera, Genoa, Italy IRCCS, European Inst Oncol, Milan, ItalyGuasone, Flavio论文数: 0 引用数: 0 h-index: 0机构: Osped Villa Scassi ASL3, Genoa, Italy IRCCS, European Inst Oncol, Milan, ItalySpinaci, Stefano论文数: 0 引用数: 0 h-index: 0机构: Osped Villa Scassi ASL3, Genoa, Italy IRCCS, European Inst Oncol, Milan, ItalyBertelsen, Bjorn-Erik论文数: 0 引用数: 0 h-index: 0机构: Haukeland Hosp, Dept Med Biochem & Pharmacol, Hormone Lab, Bergen, Norway IRCCS, European Inst Oncol, Milan, ItalyMellgren, Gunnar论文数: 0 引用数: 0 h-index: 0机构: Haukeland Hosp, Dept Med Biochem & Pharmacol, Hormone Lab, Bergen, Norway Univ Bergen, Dept Clin Sci, Bergen, Norway IRCCS, European Inst Oncol, Milan, ItalyBedrosian, Isabelle论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX USA IRCCS, European Inst Oncol, Milan, ItalyWeber, Diane论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX USA IRCCS, European Inst Oncol, Milan, ItalyCastile, Tawana论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX USA IRCCS, European Inst Oncol, Milan, ItalyDimond, Eileen论文数: 0 引用数: 0 h-index: 0机构: NCI, Div Canc Prevent, Bethesda, MD USA IRCCS, European Inst Oncol, Milan, ItalyHeckman-Stoddard, Brandy M.论文数: 0 引用数: 0 h-index: 0机构: NCI, Div Canc Prevent, Bethesda, MD USA IRCCS, European Inst Oncol, Milan, ItalySzabo, Eva论文数: 0 引用数: 0 h-index: 0机构: NCI, Div Canc Prevent, Bethesda, MD USA IRCCS, European Inst Oncol, Milan, ItalyBrown, Powel H.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX USA IRCCS, European Inst Oncol, Milan, ItalyDeCensi, Andrea论文数: 0 引用数: 0 h-index: 0机构: Ospedali Galliera, Genoa, Italy Queen Mary Univ London, Wolfson Inst Populat Hlth, London, England Ospedali Galliera, Mura Cappuccine 14, I-16128 Genoa, Italy IRCCS, European Inst Oncol, Milan, Italy论文数: 引用数: h-index:机构:
- [6] The BOLERO-2 trial: the addition of everolimus to exemestane in the treatment of postmenopausal hormone receptor-positive advanced breast cancer[J]. FUTURE ONCOLOGY, 2012, 8 (06) : 651 - 657Beaver, Julia A.论文数: 0 引用数: 0 h-index: 0机构: Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD 21287 USA Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD 21287 USAPark, Ben H.论文数: 0 引用数: 0 h-index: 0机构: Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD 21287 USA Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD 21287 USA
- [7] Randomized, controlled phase II trial of exemestane compared with medroxyprogesterone after nonsteroidal aromatase inhibitor therapy in postmenopausal women with hormone receptor-positive, advanced breast cancer[J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)Wang, T.论文数: 0 引用数: 0 h-index: 0机构: Acad Mil Med Sci, Affiliated Hosp, Dept Breast Canc, Beijing, Peoples R ChinaHuang, H.论文数: 0 引用数: 0 h-index: 0机构: Acad Mil Med Sci, Affiliated Hosp, Dept Breast Canc, Beijing, Peoples R ChinaZhang, S.论文数: 0 引用数: 0 h-index: 0机构: Acad Mil Med Sci, Affiliated Hosp, Dept Breast Canc, Beijing, Peoples R ChinaBian, L.论文数: 0 引用数: 0 h-index: 0机构: Acad Mil Med Sci, Affiliated Hosp, Dept Breast Canc, Beijing, Peoples R ChinaJiang, Z.论文数: 0 引用数: 0 h-index: 0机构: Acad Mil Med Sci, Affiliated Hosp, Dept Breast Canc, Beijing, Peoples R China
- [8] ACOSOG Z1031: A randomized phase II trial comparing exemestane, letrozole, and anastrozole in postmenopausal women with clinical stage II/III estrogen receptor-positive breast cancer[J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (18)Ellis, M. J.论文数: 0 引用数: 0 h-index: 0机构: Washington Univ, Siteman Canc Ctr, St Louis, MO USABabiera, G.论文数: 0 引用数: 0 h-index: 0机构: Washington Univ, Siteman Canc Ctr, St Louis, MO USAUnzeitig, G. W.论文数: 0 引用数: 0 h-index: 0机构: Washington Univ, Siteman Canc Ctr, St Louis, MO USAMarcom, P. K.论文数: 0 引用数: 0 h-index: 0机构: Washington Univ, Siteman Canc Ctr, St Louis, MO USAGuenther, J. M.论文数: 0 引用数: 0 h-index: 0机构: Washington Univ, Siteman Canc Ctr, St Louis, MO USADeshryver, F. K.论文数: 0 引用数: 0 h-index: 0机构: Washington Univ, Siteman Canc Ctr, St Louis, MO USAAllred, D. C.论文数: 0 引用数: 0 h-index: 0机构: Washington Univ, Siteman Canc Ctr, St Louis, MO USASuman, V.论文数: 0 引用数: 0 h-index: 0机构: Washington Univ, Siteman Canc Ctr, St Louis, MO USAHunt, K.论文数: 0 引用数: 0 h-index: 0机构: Washington Univ, Siteman Canc Ctr, St Louis, MO USAOlson, J. A.论文数: 0 引用数: 0 h-index: 0机构: Washington Univ, Siteman Canc Ctr, St Louis, MO USA
- [9] Adjuvant tamoxifen switched to exemestane treatment in postmenopausal women with estrogen receptor-positive early breast cancer: A pragmatic, multicenter, and prospective clinical trial in China[J]. Chinese Journal of Cancer Research, 2022, 34 (06) : 592 - 601Binghe Xu论文数: 0 引用数: 0 h-index: 0机构: Department of Breast Cancer, Harbin Medical University Cancer Hospital Department of Breast Cancer, Harbin Medical University Cancer HospitalHuiping Li论文数: 0 引用数: 0 h-index: 0机构: Department of Clinical Development, Pfizer (China) R&D Co.Ltd 12. Department of Statistics, Pfizer (China) R&D Co.Ltd Department of Breast Cancer, Harbin Medical University Cancer Hospital论文数: 引用数: h-index:机构:论文数: 引用数: h-index:机构:论文数: 引用数: h-index:机构:论文数: 引用数: h-index:机构:Yueyin Pan论文数: 0 引用数: 0 h-index: 0机构: Department of Breast Cancer, the Fifth Medical Center of Chinese PLA General Hospital Department of Breast Cancer, Harbin Medical University Cancer HospitalYunjiang Liu论文数: 0 引用数: 0 h-index: 0机构: Department of Breast Cancer, Tianjin Cancer Institute and Hospital Department of Breast Cancer, Harbin Medical University Cancer HospitalShude Cui论文数: 0 引用数: 0 h-index: 0机构: Department of Breast Cancer, Jiangsu Provincial Hospital Department of Breast Cancer, Harbin Medical University Cancer Hospital论文数: 引用数: h-index:机构:Li Cai论文数: 0 引用数: 0 h-index: 0机构: Department of Breast Cancer, the Fourth Hospital of Hebei Medical University Department of Breast Cancer, Harbin Medical University Cancer HospitalYiqiong Zhang论文数: 0 引用数: 0 h-index: 0机构: Department of Breast Cancer, Henan Cancer Hospital Department of Breast Cancer, Harbin Medical University Cancer HospitalHuadong Zhao论文数: 0 引用数: 0 h-index: 0机构: Department of Breast Cancer, Zhejiang Cancer Hospital Department of Breast Cancer, Harbin Medical University Cancer HospitalZhimin Shao论文数: 0 引用数: 0 h-index: 0机构: Department of Breast Cancer, Harbin Medical University Cancer Hospital
- [10] Adjuvant tamoxifen switched to exemestane treatment in postmenopausal women with estrogen receptor-positive early breast cancer: A pragmatic, multicenter, and prospective clinical trial in China[J]. CHINESE JOURNAL OF CANCER RESEARCH, 2022, 34 (06) : 592 - +Xu, Binghe论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Canc Ctr, Dept Med Oncol, Beijing 100021, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Canc Ctr, Dept Med Oncol, Beijing 100021, Peoples R ChinaLi, Huiping论文数: 0 引用数: 0 h-index: 0机构: Peking Univ Canc Hosp & Inst, Dept Breast Oncol, Minist Educ, Key Lab Carcinogenesis & Translat Res, Beijing 100142, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Canc Ctr, Dept Med Oncol, Beijing 100021, Peoples R ChinaJiang, Zefei论文数: 0 引用数: 0 h-index: 0机构: Fifth Med Ctr Chinese PLA Gen Hosp, Dept Breast Canc, Beijing 100071, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Canc Ctr, Dept Med Oncol, Beijing 100021, Peoples R ChinaGu, Lin论文数: 0 引用数: 0 h-index: 0机构: Tianjin Canc Inst & Hosp, Dept Breast Canc, Tianjin 300060, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Canc Ctr, Dept Med Oncol, Beijing 100021, Peoples R ChinaTang, Jinhai论文数: 0 引用数: 0 h-index: 0机构: Jiangsu Prov Hosp, Dept Breast Canc, Nanjing 210029, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Canc Ctr, Dept Med Oncol, Beijing 100021, Peoples R ChinaXie, Hui论文数: 0 引用数: 0 h-index: 0机构: Jiangsu Prov Hosp, Dept Breast Canc, Nanjing 210029, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Canc Ctr, Dept Med Oncol, Beijing 100021, Peoples R ChinaPan, Yueyin论文数: 0 引用数: 0 h-index: 0机构: Chinese Univ Sci & Technol, Affiliated Hosp 1, Dept Breast Canc, Hefei 230001, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Canc Ctr, Dept Med Oncol, Beijing 100021, Peoples R China论文数: 引用数: h-index:机构:Cui, Shude论文数: 0 引用数: 0 h-index: 0机构: Henan Canc Hosp, Dept Breast Canc, Zhengzhou 450008, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Canc Ctr, Dept Med Oncol, Beijing 100021, Peoples R ChinaWang, Xiaojia论文数: 0 引用数: 0 h-index: 0机构: Zhejiang Canc Hosp, Dept Breast Canc, Hangzhou 310012, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Canc Ctr, Dept Med Oncol, Beijing 100021, Peoples R China论文数: 引用数: h-index:机构:Zhang, Yiqiong论文数: 0 引用数: 0 h-index: 0机构: Pfizer China R&D Co Ltd, Dept Clin Dev, Shanghai 201203, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Canc Ctr, Dept Med Oncol, Beijing 100021, Peoples R ChinaZhao, Huadong论文数: 0 引用数: 0 h-index: 0机构: Pfizer China R&D Co Ltd, Dept Stat, Shanghai 201203, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Canc Ctr, Dept Med Oncol, Beijing 100021, Peoples R ChinaShao, Zhimin论文数: 0 引用数: 0 h-index: 0机构: Fudan Univ, Canc Inst, Shanghai Med Coll, Shanghai Canc Ctr,Dept Breast Surg, Shanghai 200032, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Canc Ctr, Dept Med Oncol, Beijing 100021, Peoples R China